These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 39062269)

  • 1. Sclerostin and Wnt Signaling in Idiopathic Juvenile Osteoporosis Using High-Resolution Confocal Microscopy for Three-Dimensional Analyses.
    Pereira RC; Noche KJ; Gales B; Chen Z; Salusky IB; Albrecht LV
    Children (Basel); 2024 Jul; 11(7):. PubMed ID: 39062269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sclerostin, Osteocytes, and Wnt Signaling in Pediatric Renal Osteodystrophy.
    Laster M; Pereira RC; Noche K; Gales B; Salusky IB; Albrecht LV
    Nutrients; 2023 Sep; 15(19):. PubMed ID: 37836411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Wnt signaling and sclerostin in bone and as therapeutic targets in skeletal disorders.
    Marini F; Giusti F; Palmini G; Brandi ML
    Osteoporos Int; 2023 Feb; 34(2):213-238. PubMed ID: 35982318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection From Glucocorticoid-Induced Osteoporosis by Anti-Catabolic Signaling in the Absence of Sost/Sclerostin.
    Sato AY; Cregor M; Delgado-Calle J; Condon KW; Allen MR; Peacock M; Plotkin LI; Bellido T
    J Bone Miner Res; 2016 Oct; 31(10):1791-1802. PubMed ID: 27163932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt signaling pathway inhibitors, sclerostin and DKK-1, correlate with pain and bone pathology in patients with Gaucher disease.
    Ivanova MM; Dao J; Kasaci N; Friedman A; Noll L; Goker-Alpan O
    Front Endocrinol (Lausanne); 2022; 13():1029130. PubMed ID: 36506070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/beta-catenin signaling.
    Lin C; Jiang X; Dai Z; Guo X; Weng T; Wang J; Li Y; Feng G; Gao X; He L
    J Bone Miner Res; 2009 Oct; 24(10):1651-61. PubMed ID: 19419300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption-formation cycles?
    Sapir-Koren R; Livshits G
    Osteoporos Int; 2014 Dec; 25(12):2685-700. PubMed ID: 25030653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sclerostin and Its Involvement in the Pathogenesis of Idiopathic Scoliosis.
    Vasiliadis ES; Evangelopoulos DS; Kaspiris A; Vlachos C; Pneumaticos SG
    J Clin Med; 2021 Nov; 10(22):. PubMed ID: 34830568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteocytes mediate the anabolic actions of canonical Wnt/β-catenin signaling in bone.
    Tu X; Delgado-Calle J; Condon KW; Maycas M; Zhang H; Carlesso N; Taketo MM; Burr DB; Plotkin LI; Bellido T
    Proc Natl Acad Sci U S A; 2015 Feb; 112(5):E478-86. PubMed ID: 25605937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sclerostin levels associated with inhibition of the Wnt/β-catenin signaling and reduced bone turnover in type 2 diabetes mellitus.
    Gaudio A; Privitera F; Battaglia K; Torrisi V; Sidoti MH; Pulvirenti I; Canzonieri E; Tringali G; Fiore CE
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3744-50. PubMed ID: 22855334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sclerostin blockade promotes bone metastases of Wnt-responsive breast cancer cells.
    Hiraga T; Horibe K; Koide M; Yamashita T; Kobayashi Y
    Cancer Sci; 2023 Jun; 114(6):2460-2470. PubMed ID: 36840409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heavy Metal Ion Regulation of Gene Expression: MECHANISMS BY WHICH LEAD INHIBITS OSTEOBLASTIC BONE-FORMING ACTIVITY THROUGH MODULATION OF THE Wnt/β-CATENIN SIGNALING PATHWAY.
    Beier EE; Sheu TJ; Dang D; Holz JD; Ubayawardena R; Babij P; Puzas JE
    J Biol Chem; 2015 Jul; 290(29):18216-18226. PubMed ID: 25975268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sclerostin and skeletal health.
    Sharifi M; Ereifej L; Lewiecki EM
    Rev Endocr Metab Disord; 2015 Jun; 16(2):149-56. PubMed ID: 25669441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fgfr1 deficiency in osteocytes leads to increased bone mass by enhancing Wnt/β-catenin signaling.
    Tang Y; Yang P; Jin M; Huang S; Chen H; Chen L; Yang J; Su N
    Bone; 2023 Sep; 174():116817. PubMed ID: 37268269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sclerostin Inhibition: A Novel Target for the Treatment of Postmenopausal Osteoporosis.
    Aditya S; Rattan A
    J Midlife Health; 2021; 12(4):267-275. PubMed ID: 35264832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sclerostin, an osteocytes-derived bone-forming inhibitor.
    Włodarski KH; Galus R; Brodzikowska A; Włodarski PK
    Pol Orthop Traumatol; 2013 Jul; 78():151-4. PubMed ID: 23820854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twist1 Inactivation in Dmp1-Expressing Cells Increases Bone Mass but Does Not Affect the Anabolic Response to Sclerostin Neutralization.
    Lewis KJ; Choi RB; Pemberton EZ; Bullock WA; Firulli AB; Robling AG
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31505764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amelioration of bone fragility by pulsed electromagnetic fields in type 2 diabetic KK-Ay mice involving Wnt/β-catenin signaling.
    Shao X; Yang Y; Tan Z; Ding Y; Luo E; Jing D; Cai J
    Am J Physiol Endocrinol Metab; 2021 May; 320(5):E951-E966. PubMed ID: 33719588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sclerostin: Intracellular mechanisms of action and its role in the pathogenesis of skeletal and vascular disorders.
    Pietrzyk B; Smertka M; Chudek J
    Adv Clin Exp Med; 2017 Nov; 26(8):1283-1291. PubMed ID: 29264888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulated serum sclerostin level in the T2DM patients with femur fracture inhibits the expression of bone formation/remodeling-associated biomarkers via antagonizing Wnt signaling.
    Wu Y; Xu SY; Liu SY; Xu L; Deng SY; He YB; Xian SC; Liu YH; Ni GX
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(3):470-478. PubMed ID: 28239825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.